Zacks Research Issues Positive Estimate for THC Earnings

Tenet Healthcare Corporation (NYSE:THC) – Zacks Research lifted their Q1 2026 EPS estimates for Tenet Healthcare in a research note issued to investors on Wednesday, February 25th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $4.14 for the quarter, up from their prior forecast of $3.73. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q2 2026 earnings at $4.10 EPS, FY2026 earnings at $16.76 EPS, Q3 2027 earnings at $4.01 EPS, Q4 2027 earnings at $3.28 EPS and FY2027 earnings at $16.35 EPS.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. During the same quarter last year, the company posted $3.44 EPS. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS.

THC has been the subject of several other reports. JPMorgan Chase & Co. lifted their target price on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Jefferies Financial Group boosted their price objective on Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a research report on Thursday, February 12th. KeyCorp lifted their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the stock an “overweight” rating in a research note on Thursday, February 12th. UBS Group increased their price objective on shares of Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Finally, Wells Fargo & Company reiterated an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a research note on Monday, February 16th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $247.67.

Tenet Healthcare Trading Up 3.3%

Shares of NYSE THC opened at $242.90 on Monday. The stock has a fifty day simple moving average of $207.62 and a 200-day simple moving average of $201.09. Tenet Healthcare has a twelve month low of $109.82 and a twelve month high of $243.72. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The stock has a market capitalization of $21.12 billion, a PE ratio of 15.68, a PEG ratio of 1.16 and a beta of 1.39.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. WCM Investment Management LLC raised its stake in Tenet Healthcare by 244.4% in the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock valued at $102,657,000 after purchasing an additional 362,083 shares during the last quarter. AlphaQuest LLC raised its position in shares of Tenet Healthcare by 238.3% in the third quarter. AlphaQuest LLC now owns 5,965 shares of the company’s stock valued at $1,211,000 after buying an additional 4,202 shares during the last quarter. Winnow Wealth LLC purchased a new position in shares of Tenet Healthcare during the third quarter valued at approximately $1,129,000. Cerity Partners LLC grew its stake in Tenet Healthcare by 10.4% in the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after acquiring an additional 11,395 shares during the period. Finally, Savant Capital LLC boosted its holdings in shares of Tenet Healthcare by 27.5% during the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after purchasing an additional 3,647 shares during the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares in the company, valued at $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 34,195 shares of company stock worth $7,912,606. Corporate insiders own 0.81% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.